Bella regularly advises companies ranging from early stage start-ups to late stage unicorns on a wide range of corporate matters. Bella started her career as a venture capital lawyer in San Francisco before moving to London. Her clients value her commercial insight into trends and norms in the Californian start-up market. Bella's practice is focused on technology start-ups with particular emphasis on consumer goods, SaaS, healthcare, and fintech.
We have advised AlveoGene, a new UK gene therapy company on its complex spinout from the Gene Therapy Consortium of Imperial College and the Universities of Oxford and Edinburgh focusing on rare respiratory diseases, as well as on its seed round investment.
Press releasevon Ross McNaughton und Bella Thornton-Clark
Leading data and analytics provider BMLL secures $21 million strategic investment
von mehreren Autoren
Advising gene therapy company AlveoGene on its complex spinout and launch investment
von mehreren Autoren
von mehreren Autoren
von Alison Dennis und Alice Matthews
von mehreren Autoren
von Thomas Kahl
von Benjamin Znaty
von Alison Dennis
von mehreren Autoren
von David Bates und Richard Faichney